Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biologic Augmentation of TMJ Arthroscopy Using BMAC
NCT07536399Phase 3Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow cell concentrate in temporomandibular joint arthralgia, sponsored by Weill Cornell Medicine. Started May 2026; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
temporomandibular joint arthralgia
Beyond the preview
Go deeper on NCT07536399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07536399.